Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zurita, A. J.
Right arrow Articles by Arap, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zurita, A. J.
Right arrow Articles by Arap, W.
[Cancer Research 64, 435-439, January 15, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Combinatorial Screenings in Patients

The Interleukin-11 Receptor {alpha} as a Candidate Target in the Progression of Human Prostate Cancer

Amado J. Zurita1, Patricia Troncoso3, Marina Cardó-Vila1, Christopher J. Logothetis1, Renata Pasqualini1,2 and Wadih Arap1,2

1 Departments of Genitourinary Medical Oncology,
2 Cancer Biology, and
3 Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Direct screening of combinatorial peptide libraries in patients may allow the identification of ligands that target biochemical differences in the endothelium of blood vessels. In a screening performed in a patient, we selected and isolated a mimic motif of interleukin 11 (IL-11) from prostate biopsies after an i.v. administration of a phage display peptide library. We also demonstrated that the IL-11 phage mimic (displaying the cyclic nonapeptide CGRRAGGSC) bound specifically to a corresponding IL-11 receptor (IL-11R{alpha}). Here we show that IL-11R{alpha} is a potential target for intervention in human prostate cancer through morphological and functional analyses. First, a comprehensive serial immunohistochemical analysis of primary and metastatic prostate cancer samples showed increased stage-specific expression of IL-11R{alpha} during disease progression. Second, a proapoptotic peptide was specifically targeted and internalized through this functional IL-11R{alpha}-based ligand-receptor pair: treatment of prostate cancer cells in vitro with a proapoptotic peptide guided by the CGRRAGGSC peptide to the IL-11R{alpha} resulted in dose-dependent apoptosis. Together, these data indicate that the IL-11R{alpha} is a candidate target for translational clinical trials against advanced and metastatic prostate cancer. Moreover, our results illustrate the ability of direct combinatorial screening systems in cancer patients for identification of relevant targets in the context of human disease.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Nishimura, S. Takahashi, H. Kamikatahira, Y. Kuroki, D. E. Jaalouk, S. O'Brien, E. Koivunen, W. Arap, R. Pasqualini, H. Nakayama, et al.
Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells
J. Biol. Chem., April 25, 2008; 283(17): 11752 - 11762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. A.H. Jarvinen and E. Ruoslahti
Molecular Changes in the Vasculature of Injured Tissues
Am. J. Pathol., August 1, 2007; 171(2): 702 - 711.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. G. Kolonin, J. Sun, K.-A. Do, C. I. Vidal, Y. Ji, K. A. Baggerly, R. Pasqualini, and W. Arap
Synchronous selection of homing peptides for multiple tissues by in vivo phage display
FASEB J, May 1, 2006; 20(7): 979 - 981.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. J. Yao, M. G. Ozawa, A. S. Varner, I. M. Kasman, Y. H. Chanthery, R. Pasqualini, W. Arap, and D. M. McDonald
Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels.
Cancer Res., March 1, 2006; 66(5): 2639 - 2649.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. G. Kolonin, L. Bover, J. Sun, A. J. Zurita, K.-A. Do, J. Lahdenranta, M. Cardo-Vila, R. J. Giordano, D. E. Jaalouk, M. G. Ozawa, et al.
Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries
Cancer Res., January 1, 2006; 66(1): 34 - 40.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Oh, I. Mohiuddin, Y. Sun, J. B. Putnam Jr, W. K. Hong, W. Arap, and R. Pasqualini
Phenotypic Diversity of the Lung Vasculature in Experimental Models of Metastases
Chest, December 1, 2005; 128(6_suppl): 596S - 600S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Oh, I. Mohiuddin, Y. Sun, J. B. Putnam Jr, W. K. Hong, W. Arap, and R. Pasqualini
Phenotypic Diversity of the Lung Vasculature in Experimental Models of Metastases
Chest, December 1, 2005; 128(6_suppl): 596S - 600S.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.